Emerging Roles for CSF-1 Receptor and its Ligands in the Nervous System

Trends in Neurosciences

Volumn 39, Issue 6, 2016, Pages 378-393

  Chitu, Violeta ^a   Gokhan, Şölen ^a   Nandi, Sayan ^a   Mehler, Mark F ^a   Stanley, E Richard ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Adult onset leukoencephalopathy with axonal spheroids and pigmented glia; IL 34; Microglia; Neural development; Neurodegenerative disease; Neuronal survival

Indexed keywords

COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR 1 RECEPTOR; INTERLEUKIN 34; LIGAND; RECEPTOR; UNCLASSIFIED DRUG; COLONY STIMULATING FACTOR RECEPTOR;

ALZHEIMER DISEASE; BRAIN CORTEX; CELL DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; DEGENERATIVE DISEASE; DEMENTIA; DEMYELINATING DISEASE; EXCITOTOXICITY; GENE MUTATION; GLIA; GLIOBLASTOMA; HOMEOSTASIS; LEUKOENCEPHALOPATHY; MACROPHAGE; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM; NEUROLOGIC DISEASE; OSTEOCLASTOGENESIS; PANETH CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; HUMAN; METABOLISM; MICROGLIA; PHOSPHORYLATION;

ANIMALS; BRAIN; HUMANS; LIGANDS; MACROPHAGE COLONY-STIMULATING FACTOR; MICROGLIA; PHOSPHORYLATION; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR;

EID: 84964380475     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2016.03.005     Document Type: Review

References (109)

1. Stanley E.R., Heard P.M. Factors regulating macrophage production and growth. Purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells. J. Biol. Chem. 1977, 252:4305-4312.
2. Lin H., et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008, 320:807-811.
3. Stanley E.R., Chitu V. CSF-1 receptor signaling in myeloid cells. Cold Spring Harb. Perspect. Biol. 2014, 6:1-21.
4. von Holst A., et al. The unique 473HD-chondroitinsulfate epitope is expressed by radial glia and involved in neural precursor cell proliferation. J. Neurosci. 2006, 26:4082-4094.
5. Wei S., et al. Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells. J. Leukoc. Biol. 2010, 88:495-505.
6. Nandi S., et al. The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Dev. Biol. 2012, 367:100-113.
7. Wang Y., et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 2012, 13:753-760.
8. Greter M., et al. Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity 2012, 37:1050-1060.
9. Akiyama H., et al. Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer's disease and amyotrophic lateral sclerosis. Brain Res. 1994, 639:171-174.
10. Raivich G., et al. Regulation of MCSF receptors on microglia in the normal and injured mouse central nervous system: a quantitative immunofluorescence study using confocal laser microscopy. J. Comp. Neurol. 1998, 395:342-358.
11. Wang Y., et al. Expression of colony stimulating factor-1 receptor (CSF-1R) by CNS neurons in mice. J. Neurosci. Res. 1999, 57:616-632.
12. Murase S., Hayashi Y. Expression pattern and neurotrophic role of the c-fms proto-oncogene M-CSF receptor in rodent Purkinje cells. J. Neurosci. 1998, 18:10481-10492.
13. Luo J., et al. Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival. J. Exp. Med. 2013, 210:157-172.
14. Sierra A., et al. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 2007, 55:412-424.
15. Erblich B., et al. Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits. PLoS ONE 2011, 6:e26317.
16. Olmos-Alonso A., et al. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology. Brain 2016, 139:891-907.
17. Sasmono R.T., et al. A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 2003, 101:1155-1163.
18. Burnett S.H., et al. Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene. J. Leukoc. Biol. 2004, 75:612-623.
19. Wang Y., et al. CSF-1 stimulated multiubiquitination of the CSF-1 receptor and of Cbl follows their tyrosine phosphorylation and association with other signaling proteins. J. Cell. Biochem. 1999, 72:119-134.
20. Chitu V., et al. Phenotypic characterization of a Csf1r haploinsufficient mouse model of adult-onset leukodystrophy with axonal spheroids and pigmented glia (ALSP). Neurobiol. Dis. 2015, 74:219-228.
21. Ryan G.R., et al. Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood 2001, 98:74-84.
22. Ginhoux F., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
23. Hristova M., et al. Activation and deactivation of periventricular white matter phagocytes during postnatal mouse development. Glia 2010, 58:11-28.
24. Miyoshi G., Fishell G. GABAergic interneuron lineages selectively sort into specific cortical layers during early postnatal development. Cereb. Cortex 2011, 21:845-852.
25. Elmore M.R., et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 2014, 82:380-397.
26. Hoeffel G., et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J. Exp. Med. 2012, 209:1167-1181.
27. Wegiel J., et al. Reduced number and altered morphology of microglial cells in colony stimulating factor-1-deficient osteopetrotic op/op mice. Brain Res. 1998, 804:135-139.
28. Sasaki A., et al. Effects of macrophage-colony-stimulating factor deficiency on the maturation of microglia and brain macrophages and on their expression of scavenger receptor. Neuropathology 2000, 20:134-142.
29. Lelli A., et al. The NADPH oxidase Nox2 regulates VEGFR1/CSF-1R-mediated microglial chemotaxis and promotes early postnatal infiltration of phagocytes in the subventricular zone of the mouse cerebral cortex. Glia 2013, 61:1542-1555.
30. Kondo Y., Duncan I.D. Selective reduction in microglia density and function in the white matter of colony-stimulating factor-1-deficient mice. J. Neurosci. Res. 2009, 87:2686-2695.
31. Johnson G.R., Burgess A.W. Molecular and biological properties of a macrophage colony-stimulating factor from mouse yolk sacs. J. Cell Biol. 1978, 77:35-47.
32. Arno B., et al. Neural progenitor cells orchestrate microglia migration and positioning into the developing cortex. Nat. Commun. 2014, 5:13.
33. Englund C., et al. Pax6, Tbr2, and Tbr1 are expressed sequentially by radial glia, intermediate progenitor cells, and postmitotic neurons in developing neocortex. J. Neurosci. 2005, 25:247-251.
34. Waisman A., et al. Homeostasis of microglia in the adult brain: review of novel microglia depletion systems. Trends Immunol. 2015, 36:625-636.
35. Parkhurst C.N., et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 2013, 155:1596-1609.
36. Dagher N.N., et al. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3×Tg-AD mice. J. Neuroinflammation 2015, 12:139.
37. Bruttger J., et al. Genetic cell ablation reveals clusters of local self-renewing microglia in the mammalian central nervous system. Immunity 2015, 43:92-106.
38. Chitu V., et al. PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts. Blood 2012, 120:3126-3135.
39. Erny D., et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 2015, 18:965-977.
40. Rademakers R., et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat. Genet. 2011, 44:200-205.
41. Nicholson A.M., et al. CSF1R mutations link POLD and HDLS as a single disease entity. Neurology 2013, 80:1033-1040.
42. Axelsson R., et al. Hereditary diffuse leucoencephalopathy with spheroids. Acta Psychiatr. Scand. Suppl. 1984, 314:1-65.
43. Van Bogaert L., Nyssen R. Le type tardif de la leukodystrophie progressive familiale. Rev. Neurol. (Paris) 1936, 65:21-45.
44. Wider C., et al. Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity?. Neurology 2009, 72:1953-1959.
45. Hoffmann S., et al. Enlarging the nosological spectrum of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS). Brain Pathol 2014, 24:452-458.
46. Sundal C., et al. MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology 2012, 79:566-574.
47. Konno T., et al. Haploinsufficiency of CSF-1R and clinicopathologic characterization in patients with HDLS. Neurology 2014, 82:139-148.
48. Kondo Y., et al. Early involvement of the corpus callosum in a patient with hereditary diffuse leukoencephalopathy with spheroids carrying the de novo K793T mutation of CSF1R. Intern. Med. 2013, 52:503-506.
49. Chitu V., et al. PDGF receptor family. The Receptor Tyrosine Kinases: Family and Subfamilies 2015, 373-538. Springer Science. 1st edn. D.L. Wheeler, Y. Yarden (Eds.).
50. Hiyoshi M., et al. M-CSF receptor mutations in hereditary diffuse leukoencephalopathy with spheroids impair not only kinase activity but also surface expression. Biochem. Biophys. Res. Commun. 2013, 440:589-593.
51. Pridans C., et al. CSF1R mutations in hereditary diffuse leukoencephalopathy with spheroids are loss of function. Sci. Rep. 2013, 3:3013.
52. Otero K., et al. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin. Nat. Immunol. 2009, 10:734-743.
53. Guan Z., et al. Injured sensory neuron-derived CSF1 induces microglial proliferation and DAP12-dependent pain. Nat. Neurosci. 2016, 19:94-101.
54. Paloneva J., et al. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat. Genet. 2000, 25:357-361.
55. Paloneva J., et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 2002, 71:656-662.
56. Takahashi K., et al. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 2005, 201:647-657.
57. Miron V.E., et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 2013, 16:1211-1218.
58. De I., et al. CSF1 overexpression has pleiotropic effects on microglia in vivo. Glia 2014, 62:1955-1967.
59. Smith A.M., et al. M-CSF increases proliferation and phagocytosis while modulating receptor and transcription factor expression in adult human microglia. J. Neuroinflammation 2013, 10:15.
60. Smith A.M., et al. Adult human glia, pericytes and meningeal fibroblasts respond similarly to IFNγ but not to TGFbeta1 or M-CSF. PLoS ONE 2013, 8:e80463.
61. Caescu C.I., et al. Colony stimulating factor-1 receptor signaling networks inhibit mouse macrophage inflammatory responses by induction of microRNA-21. Blood 2015, 125:e1-e13.
62. Berezovskaya O., et al. Colony stimulating factor-1 potentiates neuronal survival in cerebral cortex ischemic lesion. Acta Neuropathol. 1996, 92:479-486.
63. Groh J., et al. Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot-Marie-Tooth disease type 1X. Brain 2012, 135:88-104.
64. Groh J., et al. CSF-1-activated macrophages are target-directed and essential mediators of Schwann cell dedifferentiation and dysfunction in Cx32-deficient mice. Glia 2015, 63:977-986.
65. Klein D., et al. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice. Brain 2015, 138:3193-3205.
66. Uemura Y., et al. The selective M-CSF receptor tyrosine kinase inhibitor Ki20227 suppresses experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2008, 195:73-80.
67. Crespo O., et al. Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis. J. Clin. Immunol. 2011, 31:1010-1020.
68. Gomez-Nicola D., et al. Regulation of microglial proliferation during chronic neurodegeneration. J. Neurosci. 2013, 33:2481-2493.
69. Walton M.R., Dragunow I. Is CREB a key to neuronal survival?. Trends Neurosci. 2000, 23:48-53.
70. McQualter J.L., et al. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 2001, 194:873-882.
71. Hesske L., et al. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation. Brain 2010, 133:1637-1654.
72. Werner K., et al. The relative number of macrophages/microglia expressing macrophage colony-stimulating factor and its receptor decreases in multiple sclerosis lesions. Glia 2002, 40:121-129.
73. Kondo Y., et al. Macrophages counteract demyelination in a mouse model of globoid cell leukodystrophy. J. Neurosci. 2011, 31:3610-3624.
74. Lee H., et al. Defective self-renewal and differentiation of GBA-deficient neural stem cells can be restored by macrophage colony-stimulating factor. Mol. Cells 2015, 38:806-813.
75. Akiyama H., et al. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
76. Hoozemans J.J., et al. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology. CNS Neurol. Disord. Drug Targets 2011, 10:57-67.
77. Kamphuis W., et al. Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer's disease mouse model. Glia 2012, 60:615-629.
78. Murphy G.M., et al. Expression of macrophage colony-stimulating factor receptor is increased in the AbetaPP(V717F) transgenic mouse model of Alzheimer's disease. Am. J. Pathol. 2000, 157:895-904.
79. Asai H., et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat. Neurosci. 2015, 18:1584-1593.
80. Ray S., et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 2007, 13:1359-1362.
81. Boissonneault V., et al. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Brain 2009, 132:1078-1092.
82. Mizuno T., et al. Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-beta neurotoxicity. Am. J. Pathol. 2011, 179:2016-2027.
83. Pyonteck S.M., et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat. Med. 2013, 19:1264-1272.
84. Coniglio S.J., et al. Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling. Mol. Med. 2012, 18:519-527.
85. Rice R.A., et al. Elimination of microglia improves functional outcomes following extensive neuronal loss in the hippocampus. J. Neurosci. 2015, 35:9977-9989.
86. Nandi S., et al. Receptor-type protein-tyrosine phosphatase zeta is a functional receptor for interleukin-34. J. Biol. Chem. 2013, 288:21972-21986.
87. Cunningham C.L., et al. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J. Neurosci. 2013, 33:4216-4233.
88. Squarzoni P., et al. Microglia modulate wiring of the embryonic forebrain. Cell Rep. 2014, 8:1271-1279.
89. Paolicelli R.C., et al. Synaptic pruning by microglia is necessary for normal brain development. Science 2011, 333:1456-1458.
90. Wu Y., et al. Microglia: dynamic mediators of synapse development and plasticity. Trends Immunol. 2015, 36:605-613.
91. Nikodemova M., et al. Microglial numbers attain adult levels after undergoing a rapid decrease in cell number in the third postnatal week. J. Neuroimmunol. 2015, 278:280-288.
92. Marin-Teva J.L., et al. Microglia promote the death of developing Purkinje cells. Neuron 2004, 41:535-547.
93. Wakselman S., et al. Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor. J. Neurosci. 2008, 28:8138-8143.
94. Sato K. Effects of microglia on neurogenesis. Glia 2015, 63:1394-1405.
95. Ribeiro Xavier A.L., et al. A distinct population of microglia supports adult neurogenesis in the subventricular zone. J. Neurosci. 2015, 35:11848-11861.
96. Sierra A., et al. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 2010, 7:483-495.
97. Xiao F., et al. CX3 chemokine receptor 1 deficiency leads to reduced dendritic complexity and delayed maturation of newborn neurons in the adult mouse hippocampus. Neural Regen. Res. 2015, 10:772-777.
98. Walker D.G., Lue L.F. Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains. Alzheimers Res. Ther. 2015, 7:9.
99. Jin S., et al. Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells. PLoS ONE 2014, 9:e115981.
100. Peles E., et al. Multi-ligand interactions with receptor-like protein tyrosine phosphatase beta: implications for intercellular signaling. Trends Biochem. Sci. 1998, 23:121-124.
101. Kuboyama K., et al. Protein tyrosine phosphatase receptor type z negatively regulates oligodendrocyte differentiation and myelination. PLoS ONE 2012, 7:e48797.
102. Buxbaum J.D., et al. Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. Mol. Psychiatry 2008, 13:162-172.
103. Ratcliffe C.F., et al. A sodium channel signaling complex: modulation by associated receptor protein tyrosine phosphatase beta. Nat. Neurosci. 2000, 3:437-444.
104. Himburg H.A., et al. Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells. Nat. Med. 2010, 16:475-482.
105. Dai X.M., et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 2002, 99:111-120.
106. Marks S.C., Lane P.W. Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J. Hered. 1976, 67:11-18.
107. Michaelson M.D., et al. CSF-1 deficiency in mice results in abnormal brain development. Development 1996, 122:2661-2672.
108. Cohen P.E., et al. Colony-stimulating factor-1 plays a major role in the development of reproductive function in male mice. Mol. Endocrinol. 1997, 11:1636-1650.
109. Cohen P.E., et al. Colony-stimulating factor 1 regulation of neuroendocrine pathways that control gonadal function in mice. Endocrinology 2002, 143:1413-1422.